TYRA
Price
$14.50
Change
-$0.34 (-2.29%)
Updated
Oct 17 closing price
Capitalization
772.81M
12 days until earnings call
XNCR
Price
$14.77
Change
-$0.18 (-1.20%)
Updated
Oct 17 closing price
Capitalization
1.05B
23 days until earnings call
Interact to see
Advertisement

TYRA vs XNCR

Header iconTYRA vs XNCR Comparison
Open Charts TYRA vs XNCRBanner chart's image
Tyra Biosciences
Price$14.50
Change-$0.34 (-2.29%)
Volume$161.39K
Capitalization772.81M
Xencor
Price$14.77
Change-$0.18 (-1.20%)
Volume$1.94M
Capitalization1.05B
TYRA vs XNCR Comparison Chart in %
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TYRA vs. XNCR commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TYRA is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (TYRA: $14.84 vs. XNCR: $14.95)
Brand notoriety: TYRA and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TYRA: 98% vs. XNCR: 292%
Market capitalization -- TYRA: $772.81M vs. XNCR: $1.05B
TYRA [@Biotechnology] is valued at $772.81M. XNCR’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TYRA’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • TYRA’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both TYRA and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TYRA’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 2 bullish TA indicator(s).

  • TYRA’s TA Score: 5 bullish, 4 bearish.
  • XNCR’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, TYRA is a better buy in the short-term than XNCR.

Price Growth

TYRA (@Biotechnology) experienced а +7.38% price change this week, while XNCR (@Biotechnology) price change was +14.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +16.02%, and the average quarterly price growth was +79.42%.

Reported Earning Dates

TYRA is expected to report earnings on Oct 30, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($1.05B) has a higher market cap than TYRA($773M). TYRA YTD gains are higher at: 4.317 vs. XNCR (-35.727). TYRA (-121.07M) and XNCR (-125.38M) have comparable annual earnings (EBITDA) . XNCR has more cash in the bank: 444M vs. TYRA (296M). TYRA has less debt than XNCR: TYRA (6.02M) vs XNCR (67.9M). XNCR has higher revenues than TYRA: XNCR (147M) vs TYRA (0).
TYRAXNCRTYRA / XNCR
Capitalization773M1.05B73%
EBITDA-121.07M-125.38M97%
Gain YTD4.317-35.727-12%
P/E RatioN/AN/A-
Revenue0147M-
Total Cash296M444M67%
Total Debt6.02M67.9M9%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TYRAXNCR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 15 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JRSTX12.720.07
+0.55%
JH Adaptive Risk Mgd U.S. Eq T
VNVYX25.750.05
+0.19%
Natixis Vaughan Nelson Mid Cap Y
MNRGX46.830.03
+0.06%
Manor Growth
HGOAX67.06-0.12
-0.18%
Hartford Growth Opportunities A
SGDIX117.27-6.57
-5.31%
Sprott Gold Equity Institutional

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with NUVL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
-2.29%
NUVL - TYRA
48%
Loosely correlated
+2.32%
NRIX - TYRA
47%
Loosely correlated
-1.89%
AURA - TYRA
46%
Loosely correlated
-8.40%
KYMR - TYRA
43%
Loosely correlated
-1.04%
XNCR - TYRA
42%
Loosely correlated
-1.20%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-1.20%
CRNX - XNCR
60%
Loosely correlated
-1.75%
NUVL - XNCR
58%
Loosely correlated
+2.32%
CGON - XNCR
55%
Loosely correlated
-0.93%
DYN - XNCR
55%
Loosely correlated
-0.24%
IDYA - XNCR
54%
Loosely correlated
+5.67%
More